Aseem Kumar Tiwari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aseem Kumar Tiwari has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
Dinesh Arora
Department of Transfusion Medicine, Medanta – The Medicity, Gurgaon, Haryana, India
26 shared publicationsGeet Aggarwal
Department of Transfusion Medicine, Medanta-The Medicity, Gurugram, Haryana, India
23 shared publications- Geet Aggarwal
Department of Transfusion Medicine, Medanta-The Medicity, Gurgaon, India
22 shared publications Gunjan Bhardwaj
Department of Transfusion Medicine, Medanta-The Medicity, Gurgaon, Haryana, India
18 shared publicationsVimarsh Raina
Laboratory Services and Transfusion Medicine, Medanta-The Medicity, Sector-38, Gurgaon 122001, India
13 shared publicationsRavi C Dara
Department of Transfusion Medicine, Manipal Hospital, Jaipur, Rajasthan, India
9 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Scientific Scholar in Indian Journal of Medical Research
- p. 1-4
Post-test counselling outcomes among HIV-positive blood donors: A real world experience with donor notification, contact testing, and linkage to care at a tertiary-level healthcare setting
This study evaluated post-test counselling outcomes among HIV-positive blood donors at a tertiary care centre in India. Of 32 donors identified as HIV-positive, 27 were successfully contacted and 15 attended in-person counselling. Unprotected sexual exposure and multiple partners were the most common risk behaviours. All counselled donors underwent repeat testing, seven consented to partner testing (all HIV-negative), and 12 initiated antiretroviral therapy. Structured post-test counselling facilitated diagnosis confirmation, partner testing, and linkage to care. Strengthening donor-tracking and counselling systems can enhance early detection and reduce onward transmission.
- 10 September 2026
- Published by Scientific Scholar in Indian Journal of Medical Research
- p. 1-4
Open AccessPost-test counselling outcomes among HIV-positive blood donors: A real world experience with donor notification, contact testing, and linkage to care at a tertiary-level healthcare setting
This study evaluated post-test counselling outcomes among HIV-positive blood donors at a tertiary care centre in India. Of 32 donors identified as HIV-positive, 27 were successfully contacted and 15 attended in-person counselling. Unprotected sexual exposure and multiple partners were the most common risk behaviours. All counselled donors underwent repeat testing, seven consented to partner testing (all HIV-negative), and 12 initiated antiretroviral therapy. Structured post-test counselling facilitated diagnosis confirmation, partner testing, and linkage to care. Strengthening donor-tracking and counselling systems can enhance early detection and reduce onward transmission.
- 29 January 2026
- Published by Wiley in Transfusion Medicine
- Vol. 36 (4) , 411-413
Challenges associated with recall and referral strategies for HIV ‐reactive blood donors in India: Insights from a nationwide online survey
- 29 January 2026
- Published by Wiley in Transfusion Medicine
- Vol. 36 (4) , 411-413
Challenges associated with recall and referral strategies for HIV ‐reactive blood donors in India: Insights from a nationwide online survey
- 9 September 2025
- Published by Elsevier in Human Immunology
- Vol. 86 (5) , 111581
Establishing India’s first accredited EQA program in transplant immunology and Immunophenotyping: The CHIMERA® EQA experience
- 9 September 2025
- Published by Elsevier in Human Immunology
- Vol. 86 (5) , 111581
Establishing India’s first accredited EQA program in transplant immunology and Immunophenotyping: The CHIMERA® EQA experience
- 5 September 2025
- Published by Elsevier in Transplant Immunology
- Vol. 93, 102281
Pre-transplant compatibility testing: Transition from CDCXM to flow cytometry in India
- 5 September 2025
- Published by Elsevier in Transplant Immunology
- Vol. 93, 102281
Pre-transplant compatibility testing: Transition from CDCXM to flow cytometry in India
- Open Access
- 18 August 2025
- Published by Scientific Scholar in Indian Journal of Nephrology
- Vol. 35, 809-810
Improved Detection of HLA-DP Antibodies: Comparative Evaluation of LIFECODES LifeScreen Deluxe and LifeScreen XP in Class II Anti-HLA Antibody Screening
- 18 August 2025
- Published by Scientific Scholar in Indian Journal of Nephrology
- Vol. 35, 809-810
Open AccessImproved Detection of HLA-DP Antibodies: Comparative Evaluation of LIFECODES LifeScreen Deluxe and LifeScreen XP in Class II Anti-HLA Antibody Screening
- Open Access
- 22 July 2025
- Published by Wolters Kluwer Health in Asian Journal of Transfusion Science
- Vol. 20 (1) , 13-21
Performance evaluation of hematology analyzer XN-10 (Blood Bank mode) and its comparison with flow-cytometer for quality control (QC) of leukodepleted blood components: Pilot Study
BACKGROUND: The quality control of leukodepleted blood components is based on residual white blood cells (rWBCs). Routinely rWBC in leukodepleted are performed flow cytometer (FCM). Newer hematology analyzers like Sysmex XN series can count rWBC accurately. STUDY DESIGN AND MATERIALS AND METHODS: There were two study objectives: (1) to evaluate analytical performance of XN blood bank (BB) mode, and (2) to compare the measurement of rWBC and residual red blood cell between the XN BB mode and flow cytometer (FCM), considered “gold standard.” This cross sectional analytical study was conducted on three type of blood components; leukodepleted random donor platelets (LRDP), leukodepleted single donor platelets (LSDP), and leukodepleted red blood cells (LRBC) to determine performance analysis; precision (coefficients of variation), sample stability, and carry over of XN BB. Correlation and linearity was compared between XN BB and FCM. RESULTS: In precision analysis, LRBC, LRDP, and LSDP showed good repeatability (P < 0.0001). Sample stability results revealed stability of LRDP and LRBC samples till 48 h, and LSDP sample was least stable as rWBC counts changed after 5 h. No carry over was observed in any blood component in the study. While comparing XN BB and FCM, a strong correlation was observed between the two, with P > 0.05. In addition, there was an excellent linearity between expected and observed WBC counts for LRBC and LSDP in BB mode (r2 = 0.88). DISCUSSION: The analyzer performed very well with respect to precision, carry over, and stability. The new BB mode of the XN 10 hematology analyzer also showed highly comparable results with FCM, in terms of correlation and linearity, to determine rWBC. CONCLUSION: The study concluded the use of BB mode as an alternative for flow cytometric analysis for the determination of rWBC in erythrocyte concentrates, platelet concentrate, and plasma.
- 22 July 2025
- Published by Wolters Kluwer Health in Asian Journal of Transfusion Science
- Vol. 20 (1) , 13-21
Open AccessPerformance evaluation of hematology analyzer XN-10 (Blood Bank mode) and its comparison with flow-cytometer for quality control (QC) of leukodepleted blood components: Pilot Study
BACKGROUND: The quality control of leukodepleted blood components is based on residual white blood cells (rWBCs). Routinely rWBC in leukodepleted are performed flow cytometer (FCM). Newer hematology analyzers like Sysmex XN series can count rWBC accurately. STUDY DESIGN AND MATERIALS AND METHODS: There were two study objectives: (1) to evaluate analytical performance of XN blood bank (BB) mode, and (2) to compare the measurement of rWBC and residual red blood cell between the XN BB mode and flow cytometer (FCM), considered “gold standard.” This cross sectional analytical study was conducted on three type of blood components; leukodepleted random donor platelets (LRDP), leukodepleted single donor platelets (LSDP), and leukodepleted red blood cells (LRBC) to determine performance analysis; precision (coefficients of variation), sample stability, and carry over of XN BB. Correlation and linearity was compared between XN BB and FCM. RESULTS: In precision analysis, LRBC, LRDP, and LSDP showed good repeatability (P < 0.0001). Sample stability results revealed stability of LRDP and LRBC samples till 48 h, and LSDP sample was least stable as rWBC counts changed after 5 h. No carry over was observed in any blood component in the study. While comparing XN BB and FCM, a strong correlation was observed between the two, with P > 0.05. In addition, there was an excellent linearity between expected and observed WBC counts for LRBC and LSDP in BB mode (r2 = 0.88). DISCUSSION: The analyzer performed very well with respect to precision, carry over, and stability. The new BB mode of the XN 10 hematology analyzer also showed highly comparable results with FCM, in terms of correlation and linearity, to determine rWBC. CONCLUSION: The study concluded the use of BB mode as an alternative for flow cytometric analysis for the determination of rWBC in erythrocyte concentrates, platelet concentrate, and plasma.
- 8 May 2025
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (3) , 104127
Real-world evidence on effectiveness and safety of granulocyte transfusion (GT) during pre-engraftment phase in hematopoietic stem cell transplant patients: A single-centre study from north India, with mini-review of Indian studies on GT
- 8 May 2025
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (3) , 104127
Real-world evidence on effectiveness and safety of granulocyte transfusion (GT) during pre-engraftment phase in hematopoietic stem cell transplant patients: A single-centre study from north India, with mini-review of Indian studies on GT
- Open Access
- 24 January 2025
- Published by Wolters Kluwer Health in Asian Journal of Transfusion Science
- Vol. 19 (2) , 187-192
Effectiveness and safety of therapeutic plasma exchange in neurological disorders; measuring the response to treatment using Modified Rankin Scale – A single-center study
INTRODUCTION: Therapeutic plasma exchange (TPE) is commonly used as a treatment modality in varying neurological disorders. Response to TPE in neurological disorders is usually noted in “subjective” terms. We, measured response to treatment, objectively, using Modified Rankin Scale (MRS). MATERIALS AND METHODS: This was an observational prospective study in patients diagnosed with autoimmune neurological disorders (AND) who underwent TPE, in addition to intravenous immunoglobulin, and/or prednisolone. This study was carried out at a tertiary care center. Demographic data, procedure details including adverse reactions, and clinical responses were collated. Clinical response was assessed by applying MRS, in different neurological disorders, before (pre-TPE) and after TPE (post-TPE). Pre- and post-TPE clinical conditions were compared using the Wilcoxon matched-pairs signed-ranks test. RESULTS: Fifty-three patients were included, with 15 females and 38 males, who had a median age of 48 years. Seven different AND were; myasthenia gravis ( n = 11), Guillain–Barre syndrome ( n = 18), neuromyelitis Optica spectrum disorders ( n = 6); chronic inflammatory demyelinating polyneuropathy ( n = 5); autoimmune encephalitis ( n = 6); transverse myelitis ( n = 6); and multiple sclerosis ( n = 1). Patients received a median of 5 cycles of TPE and a mean 1.5 plasma volume was exchanged. The improvement in the MRS scale was significant when post-TPE scores were compared with pre-TPE scores. The most common adverse reaction was shivering ( n = 5; 1.85%), which was managed conservatively. CONCLUSION: TPE was shown to be an effective and safe treatment modality in providing relief to patients with neurological disorders.
- 24 January 2025
- Published by Wolters Kluwer Health in Asian Journal of Transfusion Science
- Vol. 19 (2) , 187-192
Open AccessEffectiveness and safety of therapeutic plasma exchange in neurological disorders; measuring the response to treatment using Modified Rankin Scale – A single-center study
INTRODUCTION: Therapeutic plasma exchange (TPE) is commonly used as a treatment modality in varying neurological disorders. Response to TPE in neurological disorders is usually noted in “subjective” terms. We, measured response to treatment, objectively, using Modified Rankin Scale (MRS). MATERIALS AND METHODS: This was an observational prospective study in patients diagnosed with autoimmune neurological disorders (AND) who underwent TPE, in addition to intravenous immunoglobulin, and/or prednisolone. This study was carried out at a tertiary care center. Demographic data, procedure details including adverse reactions, and clinical responses were collated. Clinical response was assessed by applying MRS, in different neurological disorders, before (pre-TPE) and after TPE (post-TPE). Pre- and post-TPE clinical conditions were compared using the Wilcoxon matched-pairs signed-ranks test. RESULTS: Fifty-three patients were included, with 15 females and 38 males, who had a median age of 48 years. Seven different AND were; myasthenia gravis ( n = 11), Guillain–Barre syndrome ( n = 18), neuromyelitis Optica spectrum disorders ( n = 6); chronic inflammatory demyelinating polyneuropathy ( n = 5); autoimmune encephalitis ( n = 6); transverse myelitis ( n = 6); and multiple sclerosis ( n = 1). Patients received a median of 5 cycles of TPE and a mean 1.5 plasma volume was exchanged. The improvement in the MRS scale was significant when post-TPE scores were compared with pre-TPE scores. The most common adverse reaction was shivering ( n = 5; 1.85%), which was managed conservatively. CONCLUSION: TPE was shown to be an effective and safe treatment modality in providing relief to patients with neurological disorders.